12 reports

Head & Neck Cancers Phase ## Clinical Trials, 2016 ##.

  • Neck Cancer
  • France
  • Germany
  • United States
  • Market Size

Head & Neck Cancers Phase ## Clinical Trials, 2016 ##.

  • Neck Cancer
  • France
  • Germany
  • Italy
  • Market Size

Head & Neck Cancers Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Neck Cancer
  • Pathology
  • Japan
  • Market Size

Head & Neck Cancers Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Neck Cancer
  • Pathology
  • United States
  • Market Size

Head & Neck Cancers Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Neck Cancer
  • Pathology
  • United Kingdom
  • Market Size

Head & Neck Cancers Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Neck Cancer
  • Pathology
  • Italy
  • Market Size

Head & Neck Cancers Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Neck Cancer
  • Pathology
  • Germany
  • Market Size

Head & Neck Cancers Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Neck Cancer
  • Pathology
  • France
  • Market Size

Head & Neck Cancers Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Neck Cancer
  • Pathology
  • Spain
  • Market Size

Head & Neck Cancer Pipeline Highlights – 2017 ##.

  • Cancer
  • Neck Cancer
  • Pathology
  • Product Initiative
  • NBTXR3 - HEAD & NECK CANCER
  • NBTXR3 - HEAD & NECK CANCER CLINICAL TRIAL

Summary Nanobiotix SA (Nanobiotix) is a late stage clinical company which develops nanomedicines for the treatment of cancers.The company develops first-in-class products utilizing its proprietary technology NanoXray, based on the physical mode of action of nanoparticles that increase the X-rays dose energy absorption within...

  • Cancer
  • Clinical Trial
  • Hospital
  • Lung Cancer
  • Neck Cancer
  • NBTXR3 - HEAD & NECK CANCER
  • NBTXR3 - HEAD & NECK CANCER PRODUCT OVERVIEW

Summary Nanobiotix S.A. (Nanobiotix) is a nanomedicine company that develops tools for local treatment of cancer. The company is developing product portfolio that consists of three products designed to meet specific clinical needs for different cancers, which include NBTXR3, NBTX IV, and TOPO NBTX. Its NBTXR3 nanoparticles are...

  • Cancer
  • Clinical Trial
  • Hospital
  • Lung Cancer
  • Neck Cancer